Companies which are potentially undervalued and in an acceptable financial position.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
AR	US$34.50	3.9%	-15.6%	US$10.8b	US$50.40	11.1	6.9%	n/a	Energy
SAM	US$180.21	2.3%	-3.7%	US$1.9b	US$230.39	0.9	38.4%	n/a	Food, Beverage & Tobacco
ATMU	US$54.17	4.6%	47.2%	US$4.1b	US$66.40	21.0	10.9%	0.4%	Capital Goods
TCW	CA$6.74	-2.2%	49.8%	CA$1.4b	CA$8.46	12.8	7.4%	3.3%	Energy
IMG	CA$22.41	-6.2%	122.8%	CA$12.5b	CA$36.35	9.1	5.1%	n/a	Materials
COR	US$286.95	5.6%	-3.2%	US$55.3b	US$351.00	21.9	5.6%	0.8%	Healthcare
TRLV	US$8.52	-15.6%	134.7%	US$1.6b	US$19.42	1.4	124.5%	n/a	Pharmaceuticals & Biotech
SLDE	US$18.06	8.9%	-14.4%	US$2.1b	US$25.20	4.2	-8.2%	n/a	Insurance
TRU	US$67.00	3.7%	-24.6%	US$13.1b	US$89.76	18.3	5.7%	0.7%	Commercial Services
HITI	CA$3.12	-4.6%	0%	CA$276.8m	CA$7.30	0.4	172.6%	n/a	Pharmaceuticals & Biotech
LKQ	US$26.75	3.7%	-27.8%	US$6.7b	US$40.81	13.2	14.4%	4.5%	Retail
XP	US$15.78	3.1%	-18.5%	US$8.0b	US$23.94	8.0	10.8%	1.2%	Diversified Financials
FLOC	US$20.97	-7.7%	17.5%	US$1.9b	US$31.56	20.6	37.6%	1.7%	Energy
ADUS	US$96.86	2.8%	-16.2%	US$1.8b	US$132.69	17.8	11.1%	n/a	Healthcare
SPRY	US$8.02	-16.9%	-55.6%	US$1.0b	US$28.40	8.0	65.1%	n/a	Pharmaceuticals & Biotech
RRC	US$36.31	-0.2%	-11.2%	US$8.6b	US$47.18	9.5	2.6%	1.1%	Energy
ANF	US$89.35	2.4%	11.9%	US$3.9b	US$111.30	8.0	0.9%	0%	Retail
BKR	US$56.94	-2.5%	48.6%	US$55.9b	US$71.24	18.1	4.4%	1.6%	Energy
ONDS	US$7.68	-17.2%	338.6%	US$3.9b	US$20.13	29.0	-24.2%	n/a	Tech
TRIS3	R$4.21	2.4%	-24.0%	R$983.1m	R$8.50	5.1	18.2%	10.2%	Consumer Durables
CEAB3	R$10.70	8.0%	-46.3%	R$3.2b	R$18.95	5.5	4.4%	3.2%	Retail
LAVV3	R$11.30	5.1%	-6.6%	R$2.2b	R$22.20	5.6	20.2%	14.7%	Real Estate Management and Development
TCL.A	CA$5.51	11.3%	-73.7%	CA$471.2m	CA$7.17	3.0	-30.8%	3.6%	Materials
SSRM	CA$40.34	-7.8%	134.3%	CA$8.4b	CA$61.99	10.5	10.6%	0%	Materials

Healthy potentially undervalued